SRC and cancer: In addition to Src overexpression and hyperactivation in PDAC [5], our studies and others show active Src in the nuclear compartment of cancer cell lines and patient tumors [10–13], comparable to the other tyrosine kinases reported to be functionally active in the nucleus [14, 33–35].